Position in OCGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$68,586
+$11,587 QoQ
Shares Held
37,893
-35.5% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Jump Financial, LLC holds $229,855,238 across 133 Biotechnology names. OCGN ranks #113 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
206,675 | $15,519,225 | |
| 2 | SRPT |
Sarepta Therapeutics, Inc.
|
507,828 | $11,050,337 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
|
504,143 | $10,561,795 | |
| 4 | LEGN |
Legend Biotech Corp
|
516,633 | $9,345,890 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
155,776 | $9,058,374 | |
| 6 | BNTX |
BioNTech SE
|
79,189 | $7,038,317 | |
| 7 | OLMA |
Olema Pharmaceuticals, Inc.
|
452,966 | $6,753,723 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
19,152 | $6,336,822 |
All Filings in OCGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $68,586 | 37,893 | Shares | Defined | 2026-05-14 | |
| 2025-06-30 | $56,999 | 58,762 | Shares | Defined | 2025-08-13 | |
| 2022-09-30 | $18,613 | 10,457 | Shares | Sole | 2022-11-07 | |
| No filing history on record for this holder in this stock. | ||||||